An observational study on risk of secondary cancers in chronic myeloid leukemia patients in the TKI era in the United States

INTRODUCTION: The treatment with tyrosine kinase inhibitors (TKIs) has drastically improved the outcome of chronic myeloid leukemia (CML) patients. This study was conducted to examine the risk of secondary cancers (SCs) in the CML patients who were diagnosed and treated in the TKI era in the United...

Descripción completa

Detalles Bibliográficos
Autores principales: Kumar, Vivek, Garg, Mohit, Chaudhary, Neha, Chandra, Abhinav Binod
Formato: Online Artículo Texto
Lenguaje:English
Publicado: PeerJ Inc. 2018
Materias:
Epidemiology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813591/
https://www.ncbi.nlm.nih.gov/pubmed/29456888
http://dx.doi.org/10.7717/peerj.4342

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813591/
https://www.ncbi.nlm.nih.gov/pubmed/29456888
http://dx.doi.org/10.7717/peerj.4342

Ejemplares similares